When you fundraise for the Yale School of Medicine, you are generating funds for medical education, discovery, innovation, and patient care. This support leads to advancements in the diagnosis and treatment of human diseases, innovative and collaborative research directed at improving patient care and the health of populations, advanced care in more than 100 specialties and subspecialties, and the highest quality education to prepare the next generation of medical professionals.
Through pioneering studies of insulin pumps, the development of a preventive drug, or elucidation of insulin resistance and its relationship—or not!—to obesity, advances made [at Yale] have repeatedly changed how doctors and patients grapple with diabetes.
Autoimmune diseases, such as scleroderma, that attack the skin can be deadly and disfiguring. The superficial marks borne by people with these conditions can indicate disease inside the body. In some cases, skin changes can even predict the disease’s occurrence. Yale researchers are working to understand the relationships between autoimmune disease and skin problems and how mapping them can help clinicians improve patient care.
Research on neurodegenerative diseases, such as Alzheimer's, ALS, Parkinson's, and Huntington's, examines the roles of misfolded proteins, synapse loss, and lysosomes.
Artificial intelligence and machine learning are already shaping research and patient care at Yale School of Medicine. Some of the doctors who rely on it explain how these technologies benefit both patients and science.
